Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001371796-16-000001
Filing Date
2016-09-06
Accepted
2016-09-06 13:23:46
Documents
1
Effectiveness Date
2016-09-06
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9008
  Complete submission text file 0001371796-16-000001.txt   10025
Mailing Address 135 NEWBURY STREET FRAMINGHAM MA 01701
Business Address 135 NEWBURY STREET FRAMINGHAM MA 01701 508-283-1200
Solace Therapeutics Inc (Filer) CIK: 0001371796 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-270110 | Film No.: 161870456